SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
SNAP
An SI Board Since February 1997
Posts SubjectMarks Bans Symbol
124 13 0 SNAP
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
99SNAP reports. siliconinvestor.com Cheers, Tucktuck-11/6/2000
98Yes. I bought some SNAP a time ago, some others (JohnG) always considered snapRockyBalboa-10/27/2000
97There is a discussion which begins here Message 14614973 on the Amigos thread wMike McFarland-10/27/2000
96SNAP release: finance.yahoo.com Synaptic Pharmaceutical to refocus business NERockyBalboa-9/13/2000
95synapticcorp.com <i>"During the second quarter our patent estate conMike McFarland-8/8/2000
94 Kathleen Mullinix said <i>I know that our intellectual property estate wMike McFarland-6/8/2000
93 Synaptic Sues Panlabs for Patent Infringement PARAMUS, N.J., June 5 /PRNeLuke-6/7/2000
92 Mike, Thanks for those two article. Very helpful for overall education and infMiljenko Zuanic-5/31/2000
91 adrenergic (Adrenoceptor) J Med Chem 2000 May 4;43(9):1699-1704 2-Amino-2-oxMike McFarland-5/30/2000
90 ("alpha-adrenergic technology") Bioorg Med Chem Lett 2000 Jan 17;10(Mike McFarland-3/4/2000
89 Synaptic Pharmaceutical Alpha-Adrenergic Program Update biz.yahoo.com <i>Mike McFarland-3/2/2000
88 <<...I am also pleased to say that Kissei is the first of what I hope wilMiljenko Zuanic-1/25/2000
87 Tuesday January 25, 7:03 am Eastern Time Company Press Release SOURCE: Synaptscaram(o)uche-1/25/2000
86 Tuesday December 7, 8:46 am Eastern Time Company Press Release SOURCE: Millenscaram(o)uche-12/7/1999
85 NRGN believe that NPY2 subtype receptor may be implicated in depression. Miljenko Zuanic-12/2/1999
84 <<Do you know what therapeutic indication might be relevant for either atommysdad-11/24/1999
83 On page 12 of the SNAP '98 Annual Y2 is listed as having primary indicatioMike McFarland-11/24/1999
82 Do you know what therapeutic indication might be relevant for either a Y2 recepBiotech Jim-11/24/1999
81 Nice additions to IP: patents.uspto.gov patents.uspto.govtommysdad-11/23/1999
80 Believe that Novartis has a license........ Am J Physiol 1999 Nov;277(5 Pt 2):scaram(o)uche-11/18/1999
79 the galanin article at SFGate.com....... sfgate.comscaram(o)uche-11/17/1999
78 note from the editors at sfgate, rec'd today....... <i>I have to aposcaram(o)uche-11/16/1999
77 A story on the local NBC affiliate's news this evening, describing the cravscaram(o)uche-11/15/1999
76 as expected...... grim, still lots of science....... Monday November 8, 8:05scaram(o)uche-11/8/1999
75 From a dow jones story: <<Despite stopping the clinical trials, Synaptickendall harmon-9/13/1999
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News